Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOEX.L Regulatory News (OEX)

  • There is currently no data for OEX

Update on Underwritten Rights Issue

3 Aug 2015 07:51

RNS Number : 8422U
Oilex Ltd
03 August 2015
 



ASX Announcement

 

3 August 2015

 

 

ASX: OEX

AIM: OEX

 

Update on Underwritten Rights Issue

 

Oilex Ltd (Oilex or the Company) is pleased to provide an update on the result of the previously announced Underwritten Rights Issue, and announces changes to the second tranche of the previously announced Placing.

 

As announced on 31 July 2015, 16,235,098 Rights Issue Shares have been taken up by shareholders, resulting in a shortfall in the Rights Issue of 153,241,412 shares. Under the terms of the underwriting agreement in respect of the Rights Issue, and as disclosed in the Company's announcement of 17 July 2015 (paragraph 5.7 of the Offer Booklet), as the share price of Oilex has, during the offer period, fallen below the A$0.041 Rights Issue offer price, a potential termination event has been triggered whereby the underwriter has the right to terminate the underwriting agreement.

 

In light of this development, the Company has taken steps to seek alternative participants for part of the Rights Issue shortfall. Accordingly, Zeta Resources Ltd (Zeta) has agreed to take up 62,011,067 shares by way of placement out of the Rights Issue shortfall at the Offer Price of A$0.041, for a total consideration of approximately A$2.55 million (£1.24 million, US$1.95 million) and will receive a fee of 6% that would otherwise have been paid to the underwriter. On this basis, the underwriter has agreed not to invoke its termination right under the underwriting agreement, and the underwriter (or its nominees) will take up the remaining Rights Issue shortfall.

 

As announced on 7 and 8 July 2015, Zeta's participation in the second tranche of the Placing will be settled in 2 tranches. As a result of Zeta's take up of Rights Issue shortfall shares as outlined above, and in order that it and its associates do not breach relevant Australian takeovers laws (under which, broadly, a person may not acquire shares if that would cause their and their associates' voting power to exceed 20%), Zeta has agreed that its second tranche investment will now proceed as follows (subject to approval of the resolutions proposed at the Company's General Meeting convened for 12 August 2015):

· 50,000,000 new ordinary shares will be placed with Zeta at a price of A$0.041 (2 pence) per share, to be settled immediately following the General Meeting;

· a further 124,019,608 (previously 225,490,196) new ordinary shares will be placed with Zeta at a price of A$0.0418 (2.04 pence) per share, to be settled by no later than 12 November 2015. These shares will be issued out of the authorisation to be sought at the General Meeting (covering 225,490,196 shares); and

· in lieu of the remaining shares originally envisaged to be issued to Zeta, (being 101,470,588 shares) the Company will issue A$4,243,500 (approximately £2.07 million) of 20 year, zero coupon unsecured convertible loan notes to Zeta, which will be convertible into shares at Zeta's option at any time, subject to compliance with Australian law, at a conversion price of A$0.0418 per share. The issue of these convertible notes will occur contemporaneously with the issue to Zeta of the 124,019,608 new ordinary shares referred to above. These convertible notes will be issued pursuant to the Company's placement capacity under Listing Rule 7.1 (as refreshed at the General Meeting). To the extent that the convertible notes are not converted, they will be redeemable on 30 June 2035 or such later date as agreed with Zeta. The Zeta Convertible Notes will have the right to participate in rights issues and other pro-rata issues on an "as converted" basis, subject to compliance with law.

 

 

Upon completion of the Rights Issue and Tranche 2 placing, Zeta and associates will hold approximately 275 million ordinary shares, representing approximately 19.6% of the Company's enlarged share capital (on an undiluted basis). Zeta will also hold A$4,243,500 of unsecured convertible notes, convertible into 101,470,588 ordinary shares.

 

The remaining portion of the second tranche of the Placing will proceed as previously announced and the Placing timetable remains unchanged. Given their relevance to the matters to be considered at the General Meeting, shareholders will be notified of the above changes by letter in the coming days.

 

 Managing Director of Oilex, Ron Miller, said;

"The financial support by Zeta not only in the second tranche, but now the Rights Issue shortfall is very pleasing and demonstrates their commitment to Oilex's business plan. This plan is focussed on production and cashflow from the recently independently assessed Reserves at our Cambay Field in India. We are delighted that the Rights Issue will successfully complete, leading to a General Meeting on 12 August 2015 where shareholders will have the opportunity to approve the second tranche of the Placing."

 

 

 

Yours faithfully,

  

Ron Miller

Managing Director

 

For further information, please contact the company or its advisors listed below:

 

PAC Partners Pty Ltd

Australian Broker

Andrew Shearer

Email: ashearer@pacpartners.com.au

Tel: +61 3 8633 9862

Australia

Westhouse Securities Limited

AIM Broker

Robert Finlay / Alastair Stratton

Email:  alastair.stratton@westhousesecurities.com

Tel: +44 20 7601 6100

UK

 

Strand Hanson Limited

Nominated Adviser

Rory Murphy /Ritchie Balmer

Email:  

oilex@strandhanson.co.uk

Tel: +44 20 7409 3494

UK

 

Vigo Communications

Public Relations UK

Patrick d'Ancona / Chris McMahon

Email:patrick.dancona@vigocomms.com

chris.mcmahon@vigocomms.com

Tel: +44 20 7016 9570

UK

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLIFSRTAIVIIE
Date   Source Headline
24th Aug 20177:00 amRNSCore Analysis and Review Confirms Cambay Potential
7th Aug 20177:00 amRNSExpiry of Unlisted Options
31st Jul 20177:49 amRNSSecurities Trading Policy
31st Jul 20177:00 amRNSQuarterly Report 30 June 2017
19th Jun 20177:00 amRNSPartial Receipt of Outstanding Cash Calls
19th Jun 20177:00 amRNSTrading Halt
6th Jun 20177:10 amRNSCambay PSC Workover and Project Update
30th May 20177:59 amRNSAppendix 3X P Haywood
30th May 20177:47 amRNSOilex Appoints New UK Based Non-Executive Director
23rd May 20177:00 amRNSCambay Production Update - C-73 and C-77
22nd May 20179:31 amRNSTranche 2 Unlisted Options Issued
12th May 201710:10 amRNSBhandut and Cambay Updates
10th May 20179:57 amRNSAppendix 3B Issue of Shares & Section 708 Notice
3rd May 20177:00 amRNSResults of 3 May 2017 General Meeting
28th Apr 20179:31 amRNSQuarterly Report 31 March 2017
28th Apr 20179:20 amRNSMobilisation of Workover Rig at Cambay
21st Apr 20178:19 amRNSChange of ASX Share Registry Address
21st Apr 20177:00 amRNSAward of Key Contracts Cambay-23z Core Analysis
18th Apr 20177:00 amRNSNotice of Change of Substantial Interest
6th Apr 20177:00 amRNSNotice of Change of Substantial Interest
4th Apr 20178:28 amRNSOilex Engagement via Vox Markets
3rd Apr 20177:00 amRNSNotice of General Meeting
31st Mar 20179:16 amRNSAppendix 3B Issue of Shares and Section 708 Notice
31st Mar 20177:00 amRNSOilex Investor Presentation April 2017
24th Mar 20177:00 amRNSAppendix 3B Issue of Shares and Section 708 Notice
17th Mar 20177:08 amRNSAppendix 3B
17th Mar 20177:00 amRNSManaging Director - Contract Extension
17th Mar 20177:00 amRNSAppendix 3Y J Salomon
16th Mar 20177:00 amRNSInterim Report 31 December 2016
16th Mar 20177:00 amRNSReinstatement to Official Quotation
15th Mar 201710:09 amRNSPlacement to Fund Cambay Work Programme
15th Mar 20177:00 amRNSSuspension of Trading on ASX
13th Mar 20177:00 amRNSTrading Halt
1st Mar 20177:00 amRNSCancellation of Unlisted Options
23rd Feb 20177:57 amRNSOilex Appoints New Chairman
13th Feb 20177:00 amRNSCancellation of Unlisted Options
30th Jan 20179:18 amRNSQuarterly Report 31 December 2016
30th Jan 20179:09 amRNSOilex Investor Presentation Jan Feb 2017
4th Jan 20177:00 amRNSCancellation of Unlisted Options
19th Dec 20167:00 amRNSAppendix 3B - Issue of Retention Rights
19th Dec 20167:00 amRNSAppendix 3Y J Salomon
13th Dec 20168:23 amRNSOilex tenders for 55% interest in Cambay PSC
6th Dec 20167:00 amRNSExpiry of Unlisted Options
24th Nov 20167:00 amRNSAppendix 3Y J Salomon
24th Nov 20167:00 amRNSAppendix 3B
23rd Nov 20167:00 amRNSWaiver of ASX Listing Rule 10.13.5
23rd Nov 20167:00 amRNSResults of Annual General Meeting 23 November 2016
23rd Nov 20167:00 amRNSChairman's Address to Shareholders
14th Nov 20167:00 amRNSExpiry of Unlisted Options
7th Nov 20167:00 amRNSExpiry of Unlisted Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.